Medexus Pharmaceuticals Inc.

MEDXF | PNK | 0 Sledující

$2.11

0.96%

$0.02

Sledovat

Overview Metrics Financials

Breakdown	3/31/2024 USD	3/31/2023 USD	3/31/2022 USD	3/31/2021 USD
Total revenue	113,054 +4.59%	108,096 +40.93%	76,701 -3.71%	79,660 -
Cost of revenue	53,540 +11.41%	48,058 +23.94%	38,774 +2.97%	37,655 -
Gross profit	59,514 -0.87%	60,038 +58.30%	37,927 -9.71%	42,005 -
Operating expense	48,720 -5.49%	51,549 +2.48%	50,303 +21.88%	41,274 -
Operating income	10,794 +41.77%	7,614 +150.77%	-14,996 -989.83%	-1,376 -
Pretax Income	106 +102.10%	-5,041 -31.96%	-3,820 +87.87%	-31,501 -
Tax Provision	320 +105.11%	-6,262 -565.46%	-941 +70.93%	-3,237 -
Net income	-214 -117.53%	1,221 +142.41%	-2,879 +89.81%	-28,264 -
EPS	-0.01 -115.83%	0.06 +140.00%	-0.15 +91.94%	-1.86 -
Diluted EPS	-0.01 -115.83%	0.06 +142.86%	-0.14 +92.47%	-1.86 -
Average Shares	22,321 +11.74%	19,976 +2.68%	19,454 +28.01%	15,197 -
Diluted Average Shares	22,321 +8.76%	20,524 +3.36%	19,856 +30.65%	15,197 -
EBIT	13,470 +57.27%	8,565 +1.93%	8,403 +138.75%	-21,685 -
EBITDA	19,276 +31.61%	14,646 -3.40%	15,162 +164.23%	-23,606 -

Soubory cookie používáme ke zlepšení prohlížení na webu.